One in four people experience mild, short lived systemic side effects after receiving either the Pfizer or AstraZeneca vaccine, with headache, fatigue and tenderness the most...
Researchers with the Peter O’Donnell Jr. Brain Institute at UT Southwestern have identified a new protein implicated in cell death that provides a potential therapeutic target...
In a randomized, double-blind trial of patients with acute undifferentiated agitation in the emergency department, droperidol was more effective for sedation and was associated with fewer...
In the 40-some years since the beginning of the HIV/AIDS epidemic, scientists have learned a lot about the virus, the disease, and ways to treat it....
A promising new concept published by an interdisciplinary research team in Proceedings of the National Academy of Sciences (PNAS) paves the way for major advances in...
For the first time in published literature, Le Bonheur Children’s Hospital and University of Tennessee Health Science Center (UTHSC) researchers showed that a variety of white...
The risk of developing atherosclerosis—a narrowing of the arteries as cholesterol plaque builds up, leading to obstruction of blood flow—is higher for people with autoimmune rheumatic...
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun. The trial will enroll...
University of California, Irvine biologists have developed a new genetically engineered mouse model, that unlike its predecessors, is based on the most common form of Alzheimer’s...
A pregnant woman’s exposure to tobacco smoke and pollution from road traffic can influence the development of behavioral outcomes in early childhood. This is the conclusion...
